Institute for HIV Research, Germany

Institute for HIV Research, Germany The Institute for HIV Research seeks to improve the lives of HIV-positive individuals by investigating new avenues for HIV cure and HIV vaccine strategies.

The U.S. Department of Health and Human Services (HHS) announced approximately $2.21 billion in Ryan White HIV/AIDS Prog...
08/10/2021

The U.S. Department of Health and Human Services (HHS) announced approximately $2.21 billion in Ryan White HIV/AIDS Program funding for cities, counties, states, and local community-based organizations in fiscal year (FY) 2021.

The Ryan White HIV/AIDS Program provides care and treatment services to low-income people with HIV, with a strong focus on health equity and addressing social determinants of health.

Cross-posted from HHS Press OfficeToday, the U.S. Department of Health and Human Services (HHS) announced approximately $2.21 billion in Ryan White HIV/AIDS Program funding for cities, counties, states, and local community-based organizations in fiscal year (FY) 2021.

Be with us in the 24th International AIDS Conference in Montreal, Canada, from 29 July till 2 August 2022.
17/09/2021

Be with us in the 24th International AIDS Conference in Montreal, Canada, from 29 July till 2 August 2022.

AIDS 2022 – the 24th International AIDS Conference – will take place in Montreal, Canada from 29 July – 2 August 2022.

Learn more about the hybrid conference and read the announcement at www.aids2022.org.

In case you've missed the IAS 2021 conference.. here's a summary of the key themes discussed.
17/09/2021

In case you've missed the IAS 2021 conference.. here's a summary of the key themes discussed.

What we learned at IAS 2021.

IAS President Adeeba Kamarulzaman recently discussed some of the highlights and key themes which emerged from the 11th IAS Conference on HIV Science last month.

Read her summary here: http://ow.ly/si2230rPQ20

We are glad to share with you the exciting news: The enrollment phase of STIPnet study is completed. Now the participant...
13/09/2021

We are glad to share with you the exciting news: The enrollment phase of STIPnet study is completed. Now the participants will have an observational follow-up year, before the study data are finalized and ready to be published.
+

Der 10. Deutsch-Österreichische AIDS-Kongress (DÖAK) wird wie geplant vom heute 25. bis 27. März 2021, aber in virtuelle...
25/03/2021

Der 10. Deutsch-Österreichische AIDS-Kongress (DÖAK) wird wie geplant vom heute 25. bis 27. März 2021, aber in virtueller Form, stattfinden. Das Kongressmotto des DÖAK 2021 lautet “40 Jahre HIV/AIDS – Pandemien gestern und heute“. Unter diesem Aspekt finden auch dieses Mal Workshops für alle statt, die sich im Bereich HIV/AIDS fortbilden möchten. Neben psychosozialen Themen werden Einblicke in die neuesten Forschungsergebnisse u.a. zu den Themen Antiretrovirale Therapie, PrEP und HIV-Impfung gewährt.
The 10th German-Austrian AIDS Congress (DÖAK) will take place as planned from today March 25th to 27th, 2021, but in virtual form. The congress motto of the DÖAK 2021 is "40 years of HIV/AIDS - pandemics yesterday and today". Under this aspect, workshops will also be held this time for anyone who would like to learn more about HIV/AIDS. In addition to psychosocial topics, insights will be provided into the latest research findings on topics such as antiretroviral therapy, PrEP and HIV vaccination.
+

03/12/2020

Credit: NIAIDCross-posted from NIAID NewsroomToday on World AIDS Day, we reflect both on the remarkable progress that has been made against HIV as well as the considerable challenges that remain. We now have highly effective HIV treatment and prevention methods, and work is underway to address the r...

When regularly taken, HIV Treatment works and enables individuals living with HIV to have a normal healthy long life.Und...
06/11/2020

When regularly taken, HIV Treatment works and enables individuals living with HIV to have a normal healthy long life.
Undetectable = Untransmittable
For more information: cdc.gov/StopHIVTogether/Treatment

If you're living with HIV, being undetectable is one of the best things you can do to stay healthy.

Learn more: cdc.gov/StopHIVTogether/Treatment

Our STIPnet Study brochure is now available in our study sites in Poland (Gdanks - Wroclaw - Warsaw - Szczecin)For more ...
20/10/2020

Our STIPnet Study brochure is now available in our study sites in Poland (Gdanks - Wroclaw - Warsaw - Szczecin)
For more information about STIPnet Study and participation visit our website linked in Bio, check the inclusion criteria and participate 👍🏻

Motivating results for all the manufacturers working on injectable treatment, with around 89% of people living with HIV ...
13/10/2020

Motivating results for all the manufacturers working on injectable treatment, with around 89% of people living with HIV taking part in the survey being interested in long-acting injectables.

Two-thirds of people on HIV treatment would like to switch to a long-acting injectable regimen, according to a four-country survey presented to the virtual HIV Glasgow conference this week. Healthcare professionals answering the same survey thought fewer people – a quarter – would end up switchi...

Never forget: Undetectable = Untransmittable.
01/10/2020

Never forget: Undetectable = Untransmittable.

Ready for some good news? Multiple studies show that people with HIV who get and keep an undetectable viral load have effectively no risk of transmitting sexually. Viral suppression is a powerful tool to . Learn more: https://bit.ly/2AWgosQ

American Gene Technologies (AGT) announced approval by the FDA (Food and Drug Administration) to begin Phase 1 of AGT103...
26/08/2020

American Gene Technologies (AGT) announced approval by the FDA (Food and Drug Administration) to begin Phase 1 of AGT103-T study and will conduct its Phase 1 human trial to begin enrollment in September 2020.

American Gene Technologies will begin trials in September in the Baltimore-Washington, D.C., metro area.

Finally you can get access to HIV prevention medication ''Truvada'' in China. 😀
26/08/2020

Finally you can get access to HIV prevention medication ''Truvada'' in China. 😀

China has finally approved the HIV-preventing drug Truvada for PrEP use after a lengthy campaign by LGBT+ and HIV activists

Adresse

Venusberg-Campus 1 Gebäude 63
Bonn
53127

Öffnungszeiten

Montag 09:00 - 15:00
Dienstag 09:00 - 15:00
Mittwoch 09:00 - 15:00
Donnerstag 09:00 - 15:00
Freitag 09:00 - 15:00

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Institute for HIV Research, Germany erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an Institute for HIV Research, Germany senden:

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram